Insights on increasing the translational value of your preclinical development program.
Jan 23, 2026by MD Biosciences
Diabetic neuropathy affects nearly half of individuals living with diabetes, yet its underlying biological drivers...
Jan 20, 2026by MD Biosciences
Pain and wound healing research demand models that accurately reflect human tissue structure, innervation, and...
Jan 13, 2026by MD Biosciences
Drug development rarely fails because a compound lacked activity.More often, it fails because preclinical models failed...
Jan 9, 2026by MD Biosciences
Toxicology is a defining step between exploratory research and clinical development. As programs move toward...
Dec 18, 2025by MD Biosciences
Experimental autoimmune encephalomyelitis (EAE) is one of the most widely used and well-characterized models for...
.png?width=400&height=400&name=Untitled%20design%20(3).png)
